Headline
The latest stories from AHA Today.
Oct. 26 is the deadline for health care providers to apply to the Health Resources and Services Administration for a portion of $25.5 billion in COVID-19 relief funds.
Increased health care use and intensity of services have been the key drivers of health care spending growth as the U.S. population continues to age, with hospital price growth averaging just 2% annually from 2010 to the start of the COVID-19 pandemic, according to a report released today by the…
The Department of Health and Human Services announced the HHS Racial Equity in Postpartum Care Challenge, a competition dedicated to upgrading postpartum care for Black and Native women enrolled in the Medicaid or CHIP programs.
The Centers for Medicare & Medicaid Services launched for state Medicaid agencies and stakeholders on Medicaid.gov a webpage dedicated to advancing transparency and innovation for home and community-based services.
The Centers for Medicare & Medicaid Services issued guidance on the American Rescue Plan Act requirement for state Medicaid and Children’s Health Insurance programs to cover certain COVID-19-related treatments without cost-sharing effective March 11, 2021.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Food and Drug Administration extended the shelf life for the monoclonal antibody therapy etesevimab, which currently must be administered with bamlanivimab.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., recommended a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series for certain individuals at risk for severe COVID-19, as proposed by her agency’s Advisory…
Sens. Todd Young, R-Ind., and Debbie Stabenow, D-Mich., introduced the Social Determinants Accelerator Act, AHA-supported legislation that would provide planning grants and technical assistance to help states and communities address the social determinants of health for high-need patients.
New data from Pfizer is indicating high efficacy for its COVID-19 vaccine as a booster, as well as its effectiveness among the 5-11 age group.
Gloria Kupferman, AHA’s chief data strategy officer, describes a new benchmarking resource that gives AHA members access to aggregated, de-identified hospital data with standardized metrics on denials, reimbursement and claims processing, to use for analyzing operational and financial efficiency.